Mirati Therapeutics, Inc.

Erste Asset Management GmbH

Report date

12/31/2023

Quarter

2023 Q4

Filed

11/26/2024

Shares

25,200

Value ($000)

1,485

Weight

0.0%

2019 Q1 - 2023 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	11/26/2024	1,485	0.0%	25,200	12/31/2023
2023 Q3	11/26/2024	1,143	0.0%	25,200	9/30/2023
2023 Q2	11/26/2024	919	0.0%	25,200	6/30/2023
2023 Q1	11/26/2024	925	0.0%	25,200	3/31/2023
2022 Q4	11/26/2024	1,075	0.0%	25,200	12/31/2022
2022 Q3	11/26/2024	1,763	0.0%	25,200	9/30/2022
2022 Q2	11/26/2024	1,694	0.0%	25,200	6/30/2022
2022 Q1	11/25/2024	2,097	0.0%	25,200	3/31/2022
2021 Q4	11/25/2024	3,634	0.1%	25,200	12/31/2021
2021 Q3	11/25/2024	4,391	0.1%	25,200	9/30/2021
2021 Q2	11/25/2024	2,143	0.0%	13,200	6/30/2021
2021 Q1	11/25/2024	2,191	0.1%	13,200	3/31/2021
2020 Q4	11/25/2024	2,916	0.1%	13,200	12/31/2020
2020 Q3	11/25/2024	2,208	0.1%	13,300	9/30/2020
2020 Q2	11/22/2024	1,262	0.1%	11,000	6/30/2020
2020 Q1	11/22/2024	905	0.1%	11,000	3/31/2020
2019 Q4	11/22/2024	1,413	0.1%	11,000	12/31/2019
2019 Q3	11/22/2024	929	0.0%	11,000	9/30/2019
2019 Q2	11/22/2024	1,152	0.1%	11,000	6/30/2019
2019 Q1	11/22/2024	812	0.0%	11,000	3/31/2019